Medical equipments, pharmaceuticals and personal care products

Tender description

SNBTS require to purchase a an Integrated Cell Processor” to complete a current clinical study. On completion of the current study SNBTS will manufacture large volumes of cell product for a pivotal clinical trial using the device. Two new critical advanced therapeutics products (EBV CTL bank and Improved Islet isolation) also require the use of a cell processor. SNBTS require to purchase a cell processor which is able to carry out automated CD14+ monocyte selection in a fully functionally closed CE-marked system. This is a major component of our MHRA-licensed MACTH clinical trial in cirrhosis. The equipment must also carry out the IFN-Gamma Cytokine Capture System (CCS) process. This is a vital manufacturing step in our improved process for the manufacture of Epstein Barr Virus-Specific T cells (EBV CTL).